News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Features Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3 June 24, 2014